Drugs / L-dipivefrin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07210320 | Oct 2025 → Apr 2026 | anaphylaxis, food allergy | Insignis Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-dipivefrin | “of L-dipivefrin (IN-001) Sublingual Solution Administered Via Spray Device or Oral Syringe” NCT07210320 ↗ |